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SObjectives: The objective of this study was to review the prognostic factors for increased survival after salvage
esophagectomy after definitive chemoradiotherapy for esophageal squamous carcinoma and determine the
importance of lymphadenectomy from a prognostic view.
Methods: Clinical data for all patients from January 1999 to December 2012 who underwent salvage esopha-
gectomy for residual tumor or tumor recurrence after definitive chemoradiotherapy were retrospectively
collected. Survival was determined and prognostic factors were analyzed with univariate and multivariate
analyses.
Results: Survival after 1, 3, and 5 years postoperatively was 74.4%, 39.8%, and 29.5%, respectively. The in-
dependent predictive factors for increased postoperative survival were tumor recurrence rather than residual tu-
mor as the indication for salvage surgery (P<.001; odds ratio [OR], 0.292); complete tumor resection (P<.001;
OR, 4.520); N category (P¼ .089; OR, 1.304); M category (P¼ .081; OR, 2.215), and total mediastinal dissec-
tion with 15 or more dissected mediastinal lymph nodes (P ¼ .034; OR, 0.546).
Conclusions: Salvage indications of recurrence, earlier disease, and complete tumor resection are related to
longer survival. The total area of mediastinal dissection with a sufficient number of dissected mediastinal lymph
nodes improves survival. Additional neck dissection does not add benefit. The optimal procedure for lymph node
dissection in salvage esophagectomy should be established in future studies. (J Thorac Cardiovasc Surg
2014;147:1805-11)The landmark RTOG 85-01 randomized trials clearly
demonstrated that chemoradiotherapy (CRT) is a curative
approach for squamous cell carcinoma.1 Although com-
plete response rates are high and short-term survival is
favorable after definitive CRT, locoregional tumor residual
or recurrence is not uncommon. Therefore, with increasing
experience, the number of salvage esophagectomies is ex-
pected to increase each year. Examples from the literature
demonstrate potential long-term survival and increased
morbidity and mortality after salvage esophagectomy, sug-
gesting that a reduction in the extent of lymphadenectomy
would be prudent.2 However, few articles have discussed
the extent of lymph node dissection in salvage esophagec-
tomy. The present study focused on survival after salvage
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The Journal of Thoracic and Caridentify the prognostic factors for long-term survival using
multivariate analysis and to provide evidence for the
optimal extent of lymphadenectomy from a prognostic
perspective.MATERIALS AND METHODS
Patients
Computerized and manual searches using the keyword ‘‘salvage esoph-
agectomy’’ were conducted in our patient database, and 140 patients were
found from the beginning of 1999 to the end of 2012. Thirteen patients with
cervical carcinoma and 5 patients with abdominal or gastroesophageal
junction carcinoma were excluded, as were 9 patients who underwent
emergency salvage surgery or induction therapy before definitive CRT or
other salvage therapy between definitive CRTand salvage esophagectomy.
Nine in-hospital deaths were also excluded. The study population thus
comprised 104 patients who underwent and survived salvage esophagec-
tomy for thoracic esophageal carcinoma only after failure of definitive
CRT (Figure 1). The present study was approved by the Institutional Re-
view Board and individual consent for the study was waived.
Data Collection
All patient data, including demographic characteristics, tumor location,
histology, clinical and pathologic TNM stage, surgical features, and CRT
features, were collected retrospectively. Staging was judged clinically
before definitive CRT using the sixth edition of the Union for International
Cancer Control (UICC) TNMclassification system and pathologically after
salvage surgery using the seventh edition of the UICC TNM classification
system. The demographic and preoperative characteristics are summarizeddiovascular Surgery c Volume 147, Number 6 1805
Abbreviations and Acronyms
CRT ¼ chemoradiotherapy
DFI ¼ disease-free interval
OR ¼ odds ratio
ROC ¼ receiver operating characteristic
UICC ¼ Union for International Cancer Control
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Sin Table 1. Tumor histology was squamous cell carcinoma in all patients
before definitive CRT.
Chemoradiotherapy
The details of definitive CRT with curative intent have been described
elsewhere,3,4 Briefly, CRT consisted of 3 to 5 courses of cisplatin þ
fluorouracil and concomitant radiotherapy (50.4 to 70 Gy) delivered over
6 to 7 weeks. We usually evaluated the effect of definitive CRT 1 month
later after the final day of radiation. If the patient was evaluated as
complete remission through endoscopic examination plus biopsy and
computed tomography, we performed the same examination 1 month
later. Patients who were evaluated as in complete remission again were
regarded as true complete remission. Recurrence was defined as tumor
regrowth after true complete remission with histologic confirmation.
Residual tumor occurred when true complete remission was not
achieved. In case of severe stricture or esophagitis, when biopsy was
difficult, the patient was regarded as incomplete remission or stable
disease from the result of computed tomography and positron emission
tomography, and included in the residual tumor category.
Surgical Considerations
Salvage esophagectomy was administered to patients whose tumor
persisted or recurred after definitive CRT. It did not include surgery after
tumor downstaging or performance status improvement after neoadjuvant
CRT. Salvage indication was local relapse without distant metastasis or
massive lymph node metastasis. In brief, salvage surgery should be per-
formed when curability can be anticipated to a certain degree. WhenFIGURE 1. Consort diagra
1806 The Journal of Thoracic and Cardiovascular Surresectability was uncertain, we tended to perform salvage surgery
because there was no other curative therapy for these patients. In contrast,
patients with distant metastasis, massive lymph node metastasis, apparent
T4 disease, or poor performance status or very elderly patient were not
considered for salvage esophagectomy, similar to the considerations for
planned esophagectomy.
At our institute, right transthoracic subtotal esophagectomy with
3-field lymph node dissection was the standard procedure for esopha-
geal carcinoma. However, mortality and morbidity were high during
our initial experience with this operation used under salvage conditions.
Therefore, some modifications were made to the surgical method, which
included preservation of the bronchial artery and avoidance of neck
dissection.2
In the present study, total mediastinal dissection, a term used to
describe only the dissected area, was defined as dissection involving
not only the middle and lower mediastinum but also the upper medias-
tinum. In detail, total mediastinal dissection involves, but is not limited
to, the lymph nodes along the bilateral recurrent laryngeal nerves, para-
esophageal nodes, posterior mediastinal nodes, aortopulmonary nodes,
subcarinal nodes, bilateral pulmonary hilar nodes, and supradiaphrag-
matic nodes.
After complete salvage esophagectomy, no adjuvant therapy aiming to
reduce the recurrent risk was administered to the patients. Chemotherapy,
radiation, CRT, resection of enlarged metastatic lymph node, or endoscopic
mucosa resection in cases of solitary local recurrence were used in 30 cases
of recurrence or residual tumor after salvage esophagectomy.
Follow-up
The follow-up assessments were conducted by telephone and personal
interviews until April 30, 2013. All patients were followed up, with a me-
dian follow-up time of 25.5months. The clinical end point was survival sta-
tus after salvage surgery.
Statistical Methods
Statistics were analyzed and relevant curves were created using the
SPSS 13.0 Statistics Software Package (SPSS Inc., Chicago, Ill). Unless
stated otherwise, mean values and standard deviations are reported. The
Student t test was used for comparisons between subgroups. For categoricalm for patient selection.
gery c June 2014
TABLE 1. Demographic and preoperative characteristics of 104
patients
Characteristic Value
Age at operation, y  standard deviation 62.6  7.8
Sex (male/female), n 91/13
Tumor location in thorax (upper/middle/lower), n 27/44/33
Stage judged clinically before dCRT (I/II/III/IV), n 14/31/43/16
Complete response to dCRT, n (%) 38 (36.5)
Esophagus-preserving interval after dCRT, mo (median) 3-114 (8)
dCRT, Definitive chemoradiotherapy.
Wang et al General Thoracic Surgery
G
T
Svariables, the c2 test or the Fisher exact test was used as appropriate. The
optimal cut-off number of dissected lymph nodes for predicting increased
survival was calculated by receiver operating characteristic (ROC) curve
analysis. Survival curves were constructed using the Kaplan-Meier
method, and the log-rank method was used for comparisons between
curves. Variables with a P value less than .1 were included in the multivar-
iate analysis. A Cox proportional hazards model with the backward Wald
method was used for multivariate analysis of postoperative survival. Those
variables remaining in the Cox proportional hazards model at the last step
were considered as independent risk factors.RESULTS
Optimal Cut-Off Number of Dissected Lymph Nodes
for Predicting Increased Survival
The results of ROC curve analysis (data not shown)
showed that neither the curve for dissected mediastinal
lymph node number (P ¼ .353) nor the curve for dissectedFIGURE 2. Comparison of Kaplan-Meier curves between
The Journal of Thoracic and Cartotal lymph node number (P ¼ .575) was significant to
establish an optimal cut-off value. Therefore, from the re-
sults of the ROC curves, patients were arbitrarily grouped
for the following prognostic analysis.Postoperative Survival and Predictors for Survival
After Salvage Esophagectomy
The actuarial survival 1, 3, and 5 years postoperatively
was 74.4%, 39.8%, and 29.5%, respectively. Univariate
analysis showed that tumor recurrence rather than residual
tumor was the indication for salvage surgery (Figure 2,
P¼ .012). Lower M category (P¼ .019), earlier TNM stage
(P ¼ .001), complete tumor resection (Figure 3, P<.001),
total mediastinal dissection (P¼ .010), number of dissected
mediastinal lymph nodes 15 or more (P¼ .006), total medi-
astinal dissection with 15 or more dissected mediastinal
lymph nodes (Figure 4, P ¼ .001), and total number of
dissected lymph nodes of 20 or more (P ¼ .014) were asso-
ciated with increased postoperative survival (Table 2).
Lower T category (P ¼ .070) and lower N category
(P ¼ .057) were potential factors related to longer survival
(Table 2). There was no significant difference in postopera-
tive survival between patients receiving additional neck
dissection and those without neck dissection (P ¼ .411).
The subsequent Cox proportional hazards model, the ef-
ficacy of which was determined using a c2 testsubgroups with different salvage indications, P ¼ .012.
diovascular Surgery c Volume 147, Number 6 1807
FIGURE 3. Comparison of Kaplan-Meier curves between complete resection (R0) and incomplete resection (R1/2), P<.001.
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rence rather than residual tumor was the indication for
salvage surgery (P<.001; odds ratio [OR], 0.292). Com-
plete tumor resection (P< .001; OR, 4.520), N category
(P ¼ .089; OR, 1.304); M category (P ¼ .081; OR,
2.215), and total mediastinal dissection with 15 or more
dissected mediastinal lymph nodes (P ¼ .034; OR, 0.546)
were the independent predictive factors for survival after
salvage esophagectomy (Table 2).
For 38 patients who underwent salvage esophagectomy
for tumor recurrence, postoperative survival after 1, 3, and
5 years was 87.8%, 56.0%, and 42.5%, respectively; for
66 patients who underwent salvage esophagectomy for re-
sidual tumor, postoperative survival after 1, 3, and 5 years
was 66.3%, 29.7%, and 20.1%, respectively (Figure 2,
P ¼ .012).
For 83 patients who underwent complete tumor resection
(R0 resection), postoperative survival after 1, 3, and 5 years
was 83.1%, 49.7%, and 36.9%, respectively; for 21 pa-
tients who underwent incomplete tumor resection (R1/2
resection), postoperative survival after 1, 3, and 5 years
was 38.0%, 4.1%, and 0%, respectively (Figure 3,
P<.001).
For 35 patients who underwent total mediastinal dissec-
tion with 15 or more mediastinal lymph nodes dissected,
postoperative survival after 1, 3, and 5 years was 90.5%,1808 The Journal of Thoracic and Cardiovascular Sur52.1%, and 43.5%, respectively; for 69 patients who under-
went nontotal mediastinal dissection or with less than 15
mediastinal lymph nodes dissected, postoperative survival
after 1, 3, and 5 years was 64.8%, 32.4%, and 19.6%,
respectively (Figure 4, P ¼ .001).
DISCUSSION
It has been reported in the literature that the most signif-
icant predictive factor is complete resection without resid-
ual tumor (R0),5-7 which is confirmed by the present
results. The 1- and 2-year survival after incomplete tumor
resection was 38.0% and 4.1%, respectively, consistent
with the results reported in the literature.8,9 Only by
complete resection can long-term survival be anticipated.10
Given the high postoperative morbidity and mortality after
salvage esophagectomy and the poor prognosis with incom-
plete resection, in our opinion, the objective of salvage
esophagectomy should be complete resection rather than
incomplete resection. Therefore, preoperative evaluation
of tumor resectability is important. However, accurate eval-
uation of the T factor in irradiated patients might be difficult
preoperatively, even with the help of bronchoscopy and
high-resolution computed tomography,7 and irradiated tis-
sues are difficult to distinguish from tumor during surgery.
Fibrosis is usually increased in radiation fields, and some
cancer cells are likely to be left behind in the deep layergery c June 2014
FIGURE 4. Comparison of Kaplan-Meier curves between total mediastinal dissection with more than 15 nodes dissected and nontotal mediastinal
dissection or less than 15 mediastinal nodes dissected, P ¼ .001.
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study, incomplete resection was due to a positive margin
and tumor invasion in vital organs. Thus, patients should
be carefully selected for salvage esophagectomy in experi-
enced centers that specialize in esophageal cancer.
Few studies reported in the literature have addressed the
optimal extent of lymph node dissection in salvage esoph-
agectomy from a prognostic perspective. Our previous
study demonstrated that neck dissection should be avoided
to preserve the blood supply from the bronchial branch
originating from the inferior thyroid artery, because of
the high risk of a fatal airway fistula after salvage surgery.2
The present study shows that neck dissection is not justi-
fied on any statistical analysis; however, the area of medi-
astinal dissection, the number of mediastinal lymph nodes
dissected, and the combination of area and number were
demonstrated to be potential predictive factors on univar-
iate analysis. The combination of area of mediastinal
dissection and the number of mediastinal lymph nodes
dissected was demonstrated to be one of the independent
predictive factors for survival on Cox multivariate anal-
ysis. This can probably be explained by the fact that these
2 variables, the number and the area of mediastinal lymph
nodes dissected, are correlated with each other and inter-
related with complete resection; in patients undergoingThe Journal of Thoracic and Carincomplete resection, especially in those with macroscopic
residual tumor, mediastinal dissection was more likely to
have been precluded. However, when area and number
were considered together, the effect of the combination
on postoperative survival was independent of complete tu-
mor resection. It is our view that the quality of mediastinal
dissection should be evaluated by both the number of
lymph nodes dissected and the mediastinal area dissected.
During qualified mediastinal dissection, not only the
lymph node vulnerable to metastasis but also the node
with perceptible or imperceptible metastasis can be
removed, which helps to reduce the risk of locoregional
or distant recurrence, and thus improves actuarial survival
after salvage esophagectomy. Therefore, the significance
of mediastinal dissection should not be ignored. On the
other hand, compared with mediastinal dissection in pa-
tients without previous definitive CRT, which is more
aggressive and radical, mediastinal dissection in salvage
esophagectomy is still considered conservative. Because
of the variation in inflammatory changes caused by irradi-
ation and the tumor location, lymphadenectomy in salvage
esophagectomy after definitive CRT varies case by case.
The optimal procedure for lymph node dissection in
salvage esophagectomy that is both safe and effective
has yet to be established. The present ROC curves faileddiovascular Surgery c Volume 147, Number 6 1809
TABLE 2. Univariate and multivariate analysis of prognostic factors for survival after salvage esophagectomy after definitive chemoradiotherapy
Variables
Univariate analysis Multivariate analysis
Number
of cases
Median
survival
(months)
Standard
error
(months)
95% confidence
interval
(months)
P
value
P
value
Hazard
ratio
95% confidence
interval for
hazard ratio
Age .954 — — —
65 y 50 35.1 6.8 21.7-48.5
<65 y 54 21.0 4.1 12.9-29.0
Sex .334 — — —
Male 91 24.4 5.9 12.8-36.0
Female 13 82.1 0.0 —
Tumor location .372 — — —
Upper thorax 27 17.2 3.2 10.8-23.5
Middle thorax 44 24.4 5.9 12.9-35.9
Lower thorax 33 37.8 13.3 11.8-63.8
Irradiation dose .421 — — —
60 Gy 85 27.8 5.4 17.3-38.3
<60 Gy 19 18.1 2.4 13.3-22.9
Salvage indication .012 <.001 0.292 0.167-0.513
Tumor recurrence 38 49.8 14.9 20.6-79.0
Residual tumor 66 19.2 3.8 11.8-26.6
T category (judged pathologically) .070 .549 — —
T0, is 10 53.5 10.5 32.8-74.1
T1 17 64.4 25.9 13.7-115.1
T2 15 30.1 4.2 21.8-38.4
T3 55 31.6 5.7 20.4-42.8
T4 7 15.0 0.5 14.0-16.0
N category (judged pathologically) .057 .089 1.304 0.961-1.771
N0 68 60.7 14.1 33.0-88.4
N1 24 26.1 0.8 24.5-27.7
N2 8 27.9 5.8 16.6-39.2
N3 4 24.6 13.4 0.0-50.9
M category (judged pathologically) .019 .081 2.215 0.906-5.413
M0 97 40.1 7.2 26.0-54.2
M1 7 23.3 10.9 1.9-44.7
TNM stage (judged pathologically) .001 .326 — —
0 8 53.5 8.7 36.4-70.5
I 19 64.4 — —
II 41 60.7 23.5 14.7-106.7
III 29 26.1 3.7 18.9-33.3
IV 7 23.3 10.9 1.9-44.7
Tumor resection <.001 <.001 4.520 2.480-8.237
Complete (R0) 83 37.8 4.7 28.6-47.0
Incomplete (R1/2) 21 9.4 1.9 5.6-13.2
Neck dissection .411 — — —
With 20 34.9 12.9 9.6-60.2
Without 84 25.3 5.3 15.0-35.6
Area of mediastinal dissection .010 .565 — —
Total 76 34.6 6.8 21.3-47.8
Nontotal 28 15.1 5.5 4.4-25.8
Number of mediastinal lymph nodes dissected .006 .133 — —
15 38 35.1 6.1 23.1-47.1
<15 66 19.2 5.1 9.2-29.2
Mediastinal dissection: area þ number of lymph nodes .001 .034 0.546 0.312-0.955
Total þ 15 35 39.1 27.0 0.0-92.1
Nontotal or<15 69 19.2 4.8 9.8-28.6
Number of totally dissected lymph nodes .014 .804 — —
20 62 34.9 8.3 18.7-51.2
<20 42 19.2 5.3 8.9-29.5
General Thoracic Surgery Wang et al
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Sto yield a best cut-off value for the number of lymph nodes
dissected for predicting longer survival. Therefore, based
on the current results, it can only be concluded that both
mediastinal dissection area and the number of mediastinal
lymph nodes dissected are important for improving sur-
vival. The more detailed extent of lymph node dissection
and the specific number of dissected lymph nodes for
optimal lymphadenectomy, however, should be established
in future studies.
Eight patients (7.69%) with pathologic stage 0 underwent
salvage surgery, which was comparable with the literature
(12.5%).10 These 8 patients were in the residual tumor
group, and 1 of the patients had carcinoma in situ. For pa-
tients with signs of persistent tumor on computed tomogra-
phy or positron emission tomography but without histologic
confirmation, despite the heterogeneity of the cohort, we
still believed that it was not ethical to delay salvage surgery
until we had histologic evidence. Some patients would have
lost the chance of surgery if we had waited.
The most recent literature has shown that the 3-year and
5-year postoperative survival after salvage esophagectomy
ranged from 17% to 58% and 17% to 33%, respec-
tively.6-13 The present results showed that postoperative
survival after 1, 3, and 5 years was 74.4%, 39.8%, and
29.5%, respectively. The difference in reported survival
can be explained by the different patient enrollment
criteria: (1) most studies enrolled patients with locally
advanced esophageal carcinoma, whereas the present
study included those with stage I tumors (judged
clinically) who were registered in the Japanese Clinical
Oncology Group Study (JCOG 9708)4 evaluating the effi-
cacy of definitive CRT in stage I esophageal squamous
cell carcinoma at our institution; and (2) the proportion of
patients with adenocarcinomawas different. In our institute,
squamous cell carcinoma is the only indication for defini-
tive CRT. Apart from the difference in the enrollment
criteria, the difference in surgical features is also worth
examining. Compared with transhiatal esophagectomy,
transthoracic esophagectomy is more curative with regard
to mediastinal lymph node dissection, as has been demon-
strated by the present study.
There is some evidence of a more favorable cancer prog-
nosis if salvage esophagectomy is done for recurrent rather
than for persistent disease,5 which was confirmed by the
present results. A complete response to definitive CRT
means not only complete remission of the primary lesion
and the metastatic regional lymph nodes but also success
in treating potential intramural and regional metastases.
Therefore, recurrence risk is reduced and prognosis is
improved after salvage surgery. The recurrence group
(with a longer disease-free interval [DFI]) had better sur-
vival than the persistent group (with a shorter DFI). On
further statistical analysis, however, the ROC curve failed
to give the best cut-off for DFI predicting better survivalThe Journal of Thoracic and Car(area ¼ 0.450, P ¼ .414). Similarly, ROC is not significant
to establish the best cut-off, but longer DFI is significant for
predicting better survival.
Because this was a retrospective study for esophageal
squamous cell carcinoma, and, consequently, selective
bias and heterogeneity of the patients could not be
completely averted, the present findings should be inter-
preted with caution, especially in western countries where
adenocarcinoma is the dominant histologic type. The cut-
off value for the number of mediastinal lymph nodes
dissected, which could not be established on ROC curve
analysis (P>.05), was somewhat arbitrary.
Based on the results, we conclude that a complete response
to definitive CRT, earlier disease, and complete tumor resec-
tion are related to increased survival. Total mediastinal
dissection with a sufficient number of dissected mediastinal
lymph nodes improves postoperative survival. Additional
neck dissection dose not add benefit. The optimal procedure
for lymph node dissection in salvage esophagectomy after
definitive CRT should be established in future studies.References
1. Cooper JS, Guo MD, Herskovic A, Macdonald JS, Martenson JA, Al-Sarraf M,
et al. Chemoradiotherapy of locally advanced esophageal cancer: long-term
follow-up of a prospective randomized trial (RTOG 85-01). Radiation Therapy
Oncology Group. JAMA. 1999;281:1623-7.
2. Tachimori Y, Kanamori N, Uemura N, Hokamura N, Igaki H, Kato H. Salvage
esophagectomy after high-dose chemoradiotherapy for esophageal squamous
cell carcinoma. J Thorac Cardiovasc Surg. 2009;137:49-54.
3. Kato K, Muro K, Minashi K, Ohtsu A, Ishikura S, Boku N, et al; Gastrointestinal
Oncology Study Group of the Japan Clinical Oncology Group (JCOG). Phase II
study of chemoradiotherapy with 5-fluorouracil and cisplatin for Stage II-III
esophageal squamous cell carcinoma: JCOG trial (JCOG 9906). Int J Radiat On-
col Biol Phys. 2011;81:684-90.
4. Kato H, Sato A, Fukuda H, Kagami Y, Udagawa H, Togo A, et al. A phase II trial
of chemoradiotherapy for stage I esophageal squamous cell carcinoma: Japan
Clinical Oncology Group Study (JCOG9708). Jpn J Clin Oncol. 2009;39:
638-43.
5. Smithers BM, Cullinan M, Thomas JM, Martin I, Barbour AP, Burmeister BH,
et al. Outcomes from salvage esophagectomy post definitive chemoradiotherapy
compared with resection following preoperative neoadjuvant chemoradiother-
apy. Dis Esophagus. 2007;20:471-7.
6. Chao YK, Chan SC, Chang HK, Liu YH, Wu YC, Hsieh MJ, et al. Salvage sur-
gery after failed chemoradiotherapy in squamous cell carcinoma of the esoph-
agus. Eur J Surg Oncol. 2009;35:289-94.
7. Tomimaru Y, Yano M, Takachi K, Miyashiro I, Ishihara R, Nishiyama K, et al.
Factors affecting the prognosis of patients with esophageal cancer undergoing
salvage surgery after definitive chemoradiotherapy. J SurgOncol. 2006;93:422-8.
8. Morita M, Kumashiro R, Hisamatsu Y, Nakanishi R, Egashira A, Saeki H, et al.
Clinical significance of salvage esophagectomy for remnant or recurrent cancer
following definitive chemoradiotherapy. J Gastroenterol. 2011;46:1284-91.
9. Tachimori Y. Role of salvage esophagectomy after definitive chemoradiotherapy.
Gen Thorac Cardiovasc Surg. 2009;57:71-8.
10. D’Journo XB, Michelet P, Dahan L, Doddoli C, Seitz JF, Giudicelli R, et al. In-
dications and outcome of salvage surgery for oesophageal cancer. Eur J Cardio-
thorac Surg. 2008;33:1117-23.
11. Schieman C, Wigle DA, Deschamps C, Nichols FC III, Cassivi SD, Shen KR,
et al. Salvage resections for recurrent or persistent cancer of the proximal esoph-
agus after chemoradiotherapy. Ann Thorac Surg. 2013;95:459-63.
12. Yoo C, Park JH, Yoon DH, Park SI, Kim HR, Kim JH, et al. Salvage esophagec-
tomy for locoregional failure after chemoradiotherapy in patients with advanced
esophageal cancer. Ann Thorac Surg. 2012;94:1862-8.
13. Nishimura M, Daiko H, Yoshida J, Nagai K. Salvage esophagectomy following
definitive chemoradiotherapy. Gen Thorac Cardiovasc Surg. 2007;55:461-5.diovascular Surgery c Volume 147, Number 6 1811
